recip earn momentum
price synergi
share rose post beat rais driven
organ growth synergi realiz track meet run
rate end believ track deliv ep toward
high end upwardli revis guidanc rang
y/i driven higher price cost action littl way
macro tailwind trade friction continu escal believ lin
valuat ebitda reiter buy
result post ep y/i
consensu ebitda y/i line consensu driven
organ sale growth volume price sale ex currenc rose q/q
america volume price asia-pacif volume price
volum increas q/q emea price flat
takeaway rais ep guidanc
y/i pre-report consensu expect macro
condit weaken back half year manag believ
off-set weak volum price increas cost cut believ volum
growth best flat believ would take mid-singl digit
declin ep bottom end guidanc expect ep
slightli better due synergi realiz believ
sacrif volum result price action estim
merchant price y/i us south america
china industri ga project backlog increas
last quarter due larg project singapor engin backlog
stabl q/q expect backlog add top-line growth
return cash sharehold split
approxim dividend share buyback expect net
debt current vs last quarter continu rise compani
util cash share buyback estim assum
updat estim rais ep
y/i near high end lin guid rang rais ep
y/i assum increment share repurchas
year
target base ebitda premium valuat
rel chemic sector due lin less cyclic earn profil
attract industri structur risk includ weaken global industri
product failur captur merger synergi
tr target
page
pf incom opeb cost equiti yoy plc
merger praxair ag plc largest industri ga compani world
pf revenu compani produc sell distribut atmospher gase
process gase rare gase on-site merchant packag ga busi
believ merger praxair highli accret come year believ
major cost synergi potenti preserv despit antitrust-rel divestitur
believ strong organ growth trend sustain expect stock benefit rel
earn stabil late econom cycl rate buy
valuat risk
target base ebitda premium valuat rel chemic sector
due lin less cyclic earn profil attract industri structur risk includ
weaken global industri product failur captur merger synergi
jame sheehan herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
